StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Free Report) in a report issued on Monday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Price Performance NYSEAMERICAN AMPE opened at $0.24 on Monday. Ampio Pharmaceuticals has a 52-week low of $0.18 and a 52-week high of […]
StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Get Rating) in a report published on Sunday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Price Performance Shares of AMPE stock opened at $0.24 on Friday. Ampio Pharmaceuticals has a 52 week low of $0.18 and a 52 […]
Equities research analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Rating) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the stock. Ampio Pharmaceuticals Price Performance Ampio Pharmaceuticals Company Profile (Get Rating) Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for […]
Research analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Rating) in a research note issued to investors on Thursday. The firm set a “sell” rating on the stock. Ampio Pharmaceuticals Price Performance Ampio Pharmaceuticals Company Profile (Get Rating) Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of […]
Equities researchers at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Rating) in a research note issued on Sunday. The firm set a “sell” rating on the stock. Ampio Pharmaceuticals Price Performance About Ampio Pharmaceuticals (Get Rating) Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It […]